VYNE Investor Relations Presentation
VYNE-Investor-Presentation
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
VYNE-Investor-Presentation
KOL Event – Novel InhiBET BET Inhibitor Platform
Download Yarrow Bioscience Investor Presentation
Current report
Quarterly report [Sections 13 or 15(d)]
Statement of acquisition of beneficial ownership by individuals
Registration of securities, business combinations – amendment
Statement of changes in beneficial ownership of securities